Roe J N, Smoller B R
Amira Medical, Inc., Palo Alto, CA 94303-4310, USA.
Crit Rev Ther Drug Carrier Syst. 1998;15(3):199-241.
Self-measurement of blood glucose is part of the daily routine for patients with diabetes, and healthcare professionals use these values for therapy and treatment. Healthcare providers are encouraging patients with insulin-dependent diabetes to test their blood glucose level four to six times a day to effectively manage their disease and significantly reduce the incidence of serious and costly complications. Unfortunately, people with diabetes test less than once a day on average, associating this noncompliance with pain associated with drawing blood from the finger. Glucose-monitoring techniques are under study that would allow body fluids other than blood to be used in a painless or almost painless manner. These new technologies could lead to a revolutionary advance in the treatment of diabetes, and the current research and development can now be reviewed.
自我血糖测量是糖尿病患者日常的一部分，医疗保健专业人员利用这些数值进行治疗。医疗保健提供者鼓励胰岛素依赖型糖尿病患者每天检测血糖水平四到六次，以有效控制病情并显著降低严重且昂贵的并发症的发生率。不幸的是，糖尿病患者平均每天检测不到一次，将这种不依从与手指采血带来的疼痛联系起来。目前正在研究葡萄糖监测技术，该技术将允许使用除血液以外的体液，且方式无痛或几乎无痛。这些新技术可能会给糖尿病治疗带来革命性进展，现在可以回顾一下当前的研发情况。
